Lice Treatment Market, By Product Type, By Distribution Channel, By Geography (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Lice are parasitic insects that can be found on people's heads and bodies, including the pubic area. There are three types of lice that affect humans: body lice, head lice, and pubic lice. Lice are tiny, wingless insects that feed on human blood. Lice spread from person to person through close contact and by sharing belongings. Unless treated properly, this condition can become a recurring problem. Lice treatment products are available over-the-counter (OTC) and/or with a prescription. These products help eliminate lice. Head lice survive and thrive solely on human blood, once they’re separated from the human host, they starve and perish within several hours. Nits (head lice eggs), on the other hand, generally die within a week of being released from their human host. While it’s true that an infestation of head lice is inconvenient and perhaps uncomfortable, it’s usually harmless.
Market Dynamics
Increasing prevalence of lice infestation, easy availability of lice treatment products, and a rise in awareness among people are some major factors expected to aid in the growth of the global lice treatment market during the forecast period. In October 2020, the U.S. Food and Drug Administration (FDA) approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The U.S. FDA initially approved Sklice (ivermectin) lotion, 0.5% for the treatment of head lice in patients 6 months of age and older as a prescription drug in February 2012.
Key features of the study:
This report provides an in-depth analysis of the global lice treatment market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global lice treatment market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fleming Medical Ltd, ParaPRO, LLC, Prestige Consumer Healthcare Inc., Omega Pharma (A subsidiary of Perrigo Company plc), Alliance Pharma PLC, Oystershell, Johnson & Johnson Private Limited, GSK plc, and Arbor Pharmaceuticals Inc. (A subsidiary of Azurity Pharmaceuticals, Inc.)
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global lice treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lice treatment market.
Detailed Segmentation:
Global Lice Treatment Market, By Product Type:
OTC Medication
Permethrin
Pyrethrin
Other Product Types
Prescription Medication
Ivermectin
Spinosad
Malathion
Other Prescription Medications
Global Lice Treatment Market, By Distribution Channel:
Hospitals And Clinics
Retail Pharmacies
Other Distribution Channels
Global Lice Treatment Market, By Geography:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Company Profiles
Fleming Medical Ltd
ParaPRO, LLC
Prestige Consumer Healthcare Inc.
Omega Pharma (A subsidiary of Perrigo Company plc)
Alliance Pharma PLC
Oystershell
Johnson & Johnson Private Limited
GSK plc
Arbor Pharmaceuticals Inc. (A subsidiary of Azurity Pharmaceuticals, Inc.)
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global Lice Treatment Market– COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Lice Treatment Market, By Product Type, 2018–2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
OTC Medication
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Permethrin
Pyrethrin
Other Product Types
Prescription Medication
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Ivermectin
Spinosad
Malathion
Other Prescription Medications
6. Global Lice Treatment Market, By Distribution Channel, 2018–2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018–2030
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
Other Distribution Channels
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
7. Global Lice Treatment Market, By Region, 2018–2030, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2018–2030
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2018–2030, (US$ Mn)
North Africa
Central Africa
South Africa
Rest Of The World
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2018-2030, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Mn)
8. Competitive Landscape
Fleming Medical Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
ParaPRO, LLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Prestige Consumer Healthcare Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Omega Pharma (A subsidiary of Perrigo Company plc)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Alliance Pharma PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Oystershell
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Johnson & Johnson Private Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
GSK plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Arbor Pharmaceuticals Inc. (A subsidiary of Azurity Pharmaceuticals, Inc.)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
9. Section
Research Methodology
About Us
*Browse 25 market data tables and 24 figures on “Lice Treatment Market”- Global forecast to 2030